Nutex Health (NASDAQ:NUTX) Issues Earnings Results

Nutex Health (NASDAQ:NUTX) released its earnings results on Tuesday. The company reported ($2.95) earnings per share for the quarter, topping analysts’ consensus estimates of ($5.43) by $2.48, Zacks reports. Nutex Health had a net margin of 10.76% and a return on equity of 42.08%. The business had revenue of $243.99 million for the quarter, compared to analyst estimates of $221.93 million.

Nutex Health Stock Performance

Shares of NASDAQ NUTX traded up $12.99 during mid-day trading on Wednesday, hitting $112.19. 290,371 shares of the company were exchanged, compared to its average volume of 145,949. Nutex Health has a 1-year low of $28.12 and a 1-year high of $184.27. The firm has a market cap of $623.22 million, a price-to-earnings ratio of 9.44 and a beta of -0.23. The company has a quick ratio of 2.26, a current ratio of 2.27 and a debt-to-equity ratio of 1.02. The stock has a 50 day simple moving average of $107.86 and a 200-day simple moving average of $113.32.

Analysts Set New Price Targets

Several analysts have recently weighed in on the stock. Maxim Group set a $205.00 price target on Nutex Health and gave the company a “buy” rating in a research note on Tuesday, August 26th. Wall Street Zen cut shares of Nutex Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, October 18th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Nutex Health in a report on Wednesday, October 8th. Two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $252.50.

Institutional Investors Weigh In On Nutex Health

Hedge funds and other institutional investors have recently modified their holdings of the stock. BNP Paribas Financial Markets raised its holdings in shares of Nutex Health by 966.7% in the 2nd quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock worth $40,000 after purchasing an additional 290 shares in the last quarter. Vestcor Inc bought a new stake in Nutex Health during the third quarter worth approximately $111,000. New York State Common Retirement Fund acquired a new position in Nutex Health in the second quarter worth approximately $137,000. Raymond James Financial Inc. bought a new position in shares of Nutex Health in the second quarter valued at $142,000. Finally, Bank of America Corp DE increased its holdings in shares of Nutex Health by 48.4% in the second quarter. Bank of America Corp DE now owns 3,715 shares of the company’s stock valued at $462,000 after buying an additional 1,211 shares in the last quarter. 5.32% of the stock is currently owned by institutional investors and hedge funds.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.